Tripletime vs Vero Scribe (2026)
Two Canadian documentation products aimed at different clinicians. Tripletime is built for specialists, tuned for cardiology, internal medicine and oncology, and it treats pre charting as the main event rather than an afterthought, pulling referral packages and snipped text into the note before the visit begins. Vero is the generalist with the better commercial surface: a complete self serve ladder, enumerated note types across consults, referrals and discharge summaries, evidence search and coding lookup in the same product, and a named certification. For a specialist reading a referral package before every consultation, Tripletime is doing the work that actually takes the time. Check its security wording carefully though, because it describes running on certified infrastructure rather than holding a certification of its own, which is not the same claim.
- It is built for specialists rather than for the short primary care visit, currently tuned for cardiology, internal medicine and oncology, which is where documentation burden is heaviest and least well served.
- Pre charting is the main event rather than a side feature, with three input paths feeding one note including snipped text and uploaded referral packages.
- The data commitments are unqualified and cover what this axis exists to ask, and language variation is treated as an engineering requirement rather than a caveat.
- The published commercial ladder is complete and self serve, with a trial that converts into a stated plan rather than into a quote.
- Note type coverage is broader across consults, referrals and discharge summaries, with evidence search and code lookup in the same product.
- Certification is stated with the type named and a retention position is published, which is more assurance than most vendors at this size offer.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Tripletime and Vero Scribe are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Tripletime | Vero Scribe |
|---|---|---|
| Primary category | Ambient Scribes | Ambient Scribes |
| Founded | 2024 | 2020 |
| Headquarters | London, United Kingdom | Toronto, Ontario, Canada |
| Website | tripletime.ai | veroscribe.com |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards Tripletime its top capability grade on AI Centrality and Model Supply Chain Disclosure. Set against Vero Scribe, Tripletime grades higher on Model Supply Chain Disclosure and HIPAA and BAA Posture. Its thinnest published disclosure sits on AI Governance and Bias Disclosure. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index awards Vero Scribe its top capability grade on AI Centrality and Commercial Transparency. Set against Tripletime, Vero Scribe grades higher on several axes, including Model and Technology Transparency, Security Certifications and Trust Center and AI Governance and Bias Disclosure. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose Tripletime or Vero Scribe?
On the axes where the AI Health Index separates them, Tripletime grades higher on Model Supply Chain Disclosure and HIPAA and BAA Posture, and Vero Scribe grades higher on several axes, including Model and Technology Transparency, Security Certifications and Trust Center and AI Governance and Bias Disclosure. Vero Scribe leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.
Where do Tripletime and Vero Scribe differ most?
The widest separation the AI Health Index records between Tripletime and Vero Scribe is on Model Supply Chain Disclosure, where Tripletime grades A and Vero Scribe grades B. That axis sits in the AI Capability group, so it should carry the most weight for a buyer whose binding constraint is how much of the work the model itself is trusted to do.
Where do Tripletime and Vero Scribe grade the same?
The AI Health Index grades Tripletime and Vero Scribe the same on several axes, including AI Centrality, Autonomy and Oversight Model and Clinical and Operational Evidence. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
What have Tripletime and Vero Scribe not disclosed?
At the last review, at least one of Tripletime and Vero Scribe published thin or absent detail on AI Governance and Bias Disclosure. The AI Health Index treats an absent disclosure as a gap in the public record rather than a failure of the product, so these are the axes to get in writing during diligence instead of inferring from the grade.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Ambient Scribes page.
Read one phrase carefully on Tripletime: it describes using infrastructure associated with a certification rather than holding one itself, which is the substitution this index flags repeatedly, since a hosting provider's certification evidences the infrastructure rather than the vendor's own controls. Its record system integration is also the weakest part of that record, with a claim shape this index treats as a warning.
Vero describes no review gate, confidence threshold or edit burden figure. Neither publishes an accuracy figure, a study or a named deployment, so the diligence burden sits with the buyer on both sides.